These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37944866)

  • 1. Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
    Raux B; Buchan KA; Bennett J; Christott T; Dowling MS; Farnie G; Fedorov O; Gamble V; Gileadi C; Giroud C; Huber KVM; Korczynska M; Limberakis C; Narayanan A; Owen DR; Sáez LD; Stock IA; Londregan AT
    Bioorg Med Chem Lett; 2024 Jan; 98():129546. PubMed ID: 37944866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
    Moustakim M; Christott T; Monteiro OP; Bennett J; Giroud C; Ward J; Rogers CM; Smith P; Panagakou I; Díaz-Sáez L; Felce SL; Gamble V; Gileadi C; Halidi N; Heidenreich D; Chaikuad A; Knapp S; Huber KVM; Farnie G; Heer J; Manevski N; Poda G; Al-Awar R; Dixon DJ; Brennan PE; Fedorov O
    Angew Chem Int Ed Engl; 2018 Dec; 57(50):16302-16307. PubMed ID: 30288907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.
    Kabra A; Bushweller J
    J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
    Christott T; Bennett J; Coxon C; Monteiro O; Giroud C; Beke V; Felce SL; Gamble V; Gileadi C; Poda G; Al-Awar R; Farnie G; Fedorov O
    SLAS Discov; 2019 Feb; 24(2):133-141. PubMed ID: 30359161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants.
    Ni X; Londregan AT; Owen DR; Knapp S; Chaikuad A
    ACS Chem Biol; 2021 Apr; 16(4):571-578. PubMed ID: 33749253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.
    Perlman EJ; Gadd S; Arold ST; Radhakrishnan A; Gerhard DS; Jennings L; Huff V; Guidry Auvil JM; Davidsen TM; Dome JS; Meerzaman D; Hsu CH; Nguyen C; Anderson J; Ma Y; Mungall AJ; Moore RA; Marra MA; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Gastier-Foster JM; Ross N; Smith MA
    Nat Commun; 2015 Dec; 6():10013. PubMed ID: 26635203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Based Discovery of AF9 YEATS Domain Inhibitors.
    Liu Y; Jin R; Lu H; Bian K; Wang R; Wang L; Gao R; Zhang J; Wu J; Yao X; Liu X; Liu D; Wang X; Zhang Z; Ruan K
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted roles of YEATS domain-containing proteins and novel links to neurological diseases.
    Yeewa R; Chaiya P; Jantrapirom S; Shotelersuk V; Lo Piccolo L
    Cell Mol Life Sci; 2022 Mar; 79(3):183. PubMed ID: 35279775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel isoform of the leukemia-associated MLLT1 (ENL/LTG19) protein.
    Wallingford MC; Filkins R; Adams D; Walentuk M; Salicioni AM; Visconti PE; Mager J
    Gene Expr Patterns; 2015 Jan; 17(1):11-5. PubMed ID: 25481096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.
    Garnar-Wortzel L; Bishop TR; Kitamura S; Milosevich N; Asiaban JN; Zhang X; Zheng Q; Chen E; Ramos AR; Ackerman CJ; Hampton EN; Chatterjee AK; Young TS; Hull MV; Sharpless KB; Cravatt BF; Wolan DW; Erb MA
    ACS Cent Sci; 2021 May; 7(5):815-830. PubMed ID: 34079898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The leukemia-associated gene Mllt1/ENL: characterization of a murine homolog and demonstration of an essential role in embryonic development.
    Doty RT; Vanasse GJ; Disteche CM; Willerford DM
    Blood Cells Mol Dis; 2002; 28(3):407-17. PubMed ID: 12367585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule tools for YEATS domain proteins.
    Erb MA
    Curr Opin Chem Biol; 2023 Dec; 77():102404. PubMed ID: 37924571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of binding preferences of YEATS domains to site-specific acetylated nucleosome core particles.
    Kikuchi M; Morita S; Goto M; Wakamori M; Katsura K; Hanada K; Shirouzu M; Umehara T
    J Biol Chem; 2022 Aug; 298(8):102164. PubMed ID: 35732209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Ligand Discovery for the ENL YEATS Domain.
    Asiaban JN; Milosevich N; Chen E; Bishop TR; Wang J; Zhang Y; Ackerman CJ; Hampton EN; Young TS; Hull MV; Cravatt BF; Erb MA
    ACS Chem Biol; 2020 Apr; 15(4):895-903. PubMed ID: 32176478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Recognition of Methacryllysine and Crotonyllysine by the AF9 YEATS Domain.
    Bilgin N; Moesgaard L; Rahman MM; Türkmen VA; Kongsted J; Mecinović J
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Coupling of Histone Crotonylation and Active Transcription by AF9 YEATS Domain.
    Li Y; Sabari BR; Panchenko T; Wen H; Zhao D; Guan H; Wan L; Huang H; Tang Z; Zhao Y; Roeder RG; Shi X; Allis CD; Li H
    Mol Cell; 2016 Apr; 62(2):181-193. PubMed ID: 27105114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation.
    Jiang Y; Chen G; Li XM; Liu S; Tian G; Li Y; Li X; Li H; Li XD
    J Am Chem Soc; 2020 Dec; 142(51):21450-21459. PubMed ID: 33306911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking.
    Li X; Li XM; Jiang Y; Liu Z; Cui Y; Fung KY; van der Beelen SHE; Tian G; Wan L; Shi X; Allis CD; Li H; Li Y; Li XD
    Nat Chem Biol; 2018 Dec; 14(12):1140-1149. PubMed ID: 30374167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain.
    Ma XR; Xu L; Xu S; Klein BJ; Wang H; Das S; Li K; Yang KS; Sohail S; Chapman A; Kutateladze TG; Shi X; Liu WR; Wen H
    J Med Chem; 2021 Aug; 64(15):10997-11013. PubMed ID: 34279931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
    Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.